Takeaways: The decision strengthens Pfizer’s foothold in Canada’s publicly funded pediatric pneumococcal market by making Prevnar 20 the standard for infants in two large provinces, wh...
Browsing Tag: pediatric infectious diseases
Takeaways: The decision strengthens Pfizer’s foothold in Canada’s publicly funded pediatric pneumococcal market by making Prevnar 20 the standard for infants in two large provinces, wh...